全文获取类型
收费全文 | 461篇 |
免费 | 16篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 3篇 |
妇产科学 | 4篇 |
基础医学 | 19篇 |
口腔科学 | 2篇 |
临床医学 | 29篇 |
内科学 | 31篇 |
皮肤病学 | 1篇 |
神经病学 | 8篇 |
特种医学 | 11篇 |
外科学 | 63篇 |
综合类 | 71篇 |
预防医学 | 44篇 |
眼科学 | 10篇 |
药学 | 152篇 |
中国医学 | 22篇 |
肿瘤学 | 7篇 |
出版年
2024年 | 7篇 |
2023年 | 11篇 |
2022年 | 14篇 |
2021年 | 10篇 |
2020年 | 12篇 |
2019年 | 17篇 |
2018年 | 10篇 |
2017年 | 15篇 |
2016年 | 22篇 |
2015年 | 11篇 |
2014年 | 28篇 |
2013年 | 36篇 |
2012年 | 33篇 |
2011年 | 34篇 |
2010年 | 26篇 |
2009年 | 34篇 |
2008年 | 24篇 |
2007年 | 24篇 |
2006年 | 25篇 |
2005年 | 13篇 |
2004年 | 14篇 |
2003年 | 10篇 |
2002年 | 9篇 |
2001年 | 7篇 |
2000年 | 4篇 |
1999年 | 4篇 |
1998年 | 1篇 |
1997年 | 2篇 |
1996年 | 4篇 |
1995年 | 1篇 |
1994年 | 1篇 |
1993年 | 4篇 |
1992年 | 4篇 |
1991年 | 2篇 |
1990年 | 2篇 |
1989年 | 4篇 |
1988年 | 2篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1978年 | 1篇 |
1977年 | 2篇 |
排序方式: 共有490条查询结果,搜索用时 46 毫秒
1.
《Vaccine》2019,37(47):6987-6995
Vero cells are nowadays widely used in the production of human vaccines. They are considered as one of the most productive and flexible continuous cell lines available for vaccine manufacturing. However, these cells are anchorage dependent, which greatly complicates upstream processing and process scale-up. Moreover, there is a recognized need to reduce the costs of vaccine manufacturing to develop vaccines that are affordable worldwide. The use of cell lines adapted to suspension growth contributes to reach this objective.The current work describes the adaptation of Vero cells to suspension culture in different serum free media according to multiple protocols based on subsequent passages. The best one that relies on cell adaption to IPT-AFM an in-house developed animal component free medium was then chosen for further studies. Besides, as aggregates have been observed, the improvement of IPT-AFM composition and mechanical dissociation were also investigated.In addition to IPT-AFM, three chemically defined media (CD293, Hycell CHO and CD-U5) and two serum free media (293SFMII and SFM4CHO) were tested to set up a serum free culture of the suspension-adapted Vero cells (VeroS) in shake flasks. Cell density levels higher than 2 × 106 cells/mL were obtained in the assessed conditions. The results were comparable to those obtained in spinner culture of adherent Vero cells grown on Cytodex 1 microcarriers.Cell infection with LP-2061 rabies virus strain at an MOI (Multiplicity of Infection) of 0.1 and a cell density of 8 ± 0.5 × 105 cells/mL resulted in a virus titer higher than 107 FFU/mL in all media tested. Nevertheless, the highest titer equal to 5.2 ± 0.5 × 107 FFU/mL, was achieved in IPT-AFM containing a reduced amount of Ca++ and Mg++. Our results demonstrate the suitability of the obtained VeroS cells to produce rabies virus at a high titer, and pave the way to develop VeroS cells bioreactor process for rabies vaccine production. 相似文献
2.
悬浮阵列技术在研究与临床中的应用 总被引:3,自引:2,他引:1
悬浮阵列技术是一种以荧光编码微球为核心,集流式细胞、激光分析、高速数字信号处理等多种技术于一体的多指标并行分析技术平台,可一次同时准确定量检测100种不同的生物分子;具有高通量、高灵敏度,并行检测等特点;常用于免疫分析、核酸研究、酶学分析、受体、配体识别分析等研究. 相似文献
3.
4.
曲马多药树脂速释混悬剂的研制 总被引:12,自引:0,他引:12
为掩盖盐酸曲马多的苦味 ,并达到迅速镇痛的目的 ,利用盐酸曲马多与离子交换树脂结合制成药物树脂的制备方法 ,进行了曲马多药树脂速释混悬剂的研制实验。实验结果表明 ,该制备方法简单 ,研制出的曲马多药树脂速释混悬剂稳定、口味好、释放迅速 相似文献
5.
[目的]了解25%氯硝柳胺悬浮剂(SCN)在丘陵山区果园内灭螺效果,并进行成本-效果评价。[方法]选择宜兴市山丘地区2处有螺果园为试验现场,采用灭螺机喷洒的方法,实验组用SCN按2.0g/m2、对照组用50%氯硝柳胺乙醇胺盐可湿性粉剂(WPN)按4.0g/m2喷洒灭螺,比较两组有螺面积下降率和活螺密度下降率;以有螺面积下降率和活螺密度下降率作为评价指标进行成本-效果分析。[结果]实验组用SCN喷洒4次,灭螺后30d有螺面积下降率和活螺密度下降率均为100.0%,有螺面积和活螺密度每下降1个百分点的费用均为56.00元,分别优于对照组WPN的99.00%、92.25%和92.93元、99.73元。[结论]用SCN山区灭螺,操作方便,成本低,灭螺效果好,具有良好应用前景。 相似文献
6.
臭氧水消毒器对微生物杀灭效果的试验观察 总被引:1,自引:0,他引:1
目的:观察臭氧水消毒器产生臭氧水的杀菌效果。方法:采用悬液定量和载体定量杀菌试验进行检测。结果:该机产生含臭氧4.20mg/L的水溶液对大肠杆菌、金黄色葡萄球菌和白色念珠菌作用5min的杀灭率均为100%;当菌液中含有10%蛋白胨时,对大肠杆菌、金黄色葡萄球菌和白色念珠菌作用5min的杀灭率分别为55.67%、59.48%和37.44%。用消毒液流动浸泡载体定量杀菌试验,含臭氧4.20mg/L的水溶液作用30min对大肠杆菌、金黄色葡萄球菌和白色念珠菌的平均杀灭率分别为99.95%、99.99%和96.94%。结论:该臭氧水消毒器产生的臭氧水具有一定消毒效果。 相似文献
7.
男性获得性尿失禁是指男性因外伤或手术导致括约肌受损或后天性神经源性疾病造成机体失去控制尿液的能力。相对于治疗金标准人工尿道括约肌植入术,悬吊术操作简单,费用低廉,疗效可靠,并发症少,在近年逐渐被医患所接受。该文就悬吊术治疗男性获得性尿失禁的研究进展予以综述。 相似文献
8.
Rongrong Liu Qian Zhou Qian Zhang Ping Zhang 《Journal of biomaterials science. Polymer edition》2016,27(12):1248-1261
Two types of shape memory poly carbonate urethanes (PCUs) microspheres were synthesized by pre-polymerization and suspension polymerization, based on Polycarbonate diol (PCDL) as the soft segment, Isophorone diisocyanate (IPDI) and 1,6-hexamethylene diisocyanate (HDI) as the hard segments and 1,4-butanediol (BDO) as the chain expanding agent. The structure, crystallinity, and thermal property of the two synthesized PCUs were characterized by Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), Differential scanning calorimetery (DSC), respectively. The results showed that the two types of PCUs exhibited high thermal stability with phase separation and semi-crystallinity. Also, the results of the compression test displayed that the shape fixity and the shape recovery of two PCUs were more than 90% compared to the originals, indicating their similar bio-applicability and shape-memory properties. The tensile strength, elongation at break was enhanced by introducing and increasing content of HDI. The water contact angles of PCUs decreased and their surface tension increased by surface modified with Bovine serum albumin (BSA). Furthermore, the biological study results of two types of PCUs from the platelet adhesion test and the cell proliferation inhibition test indicated they had some biocompatibilites. Hence, the PCU microspheres might represent a smart and shape-memory embolic agent for vascular embolization. 相似文献
9.
《Vaccine》2017,35(26):3423-3430
Despite major advances in developing capacities and alternative technologies to egg-based production of influenza vaccines, responsiveness to an influenza pandemic threat is limited by the time it takes to generate a Candidate Vaccine Virus (CVV) as reported by the 2015 WHO Informal Consultation report titled “Influenza Vaccine Response during the Start of a Pandemic”.In previous work, we have shown that HEK-293 cell culture in suspension and serum free medium is an efficient production platform for cell culture manufacturing of influenza candidate vaccines. This report, took advantage of, recombinant DNA technology using Reverse Genetics of influenza strains, and advances in the large-scale transfection of suspension cultured HEK-293 cells. We demonstrate the efficient generation of H1N1 with the PR8 backbone reassortant under controlled bioreactor conditions in two sequential steps (transfection/rescue and infection/production). This approach could deliver a CVV for influenza vaccine manufacturing within two-weeks, starting from HA and NA pandemic sequences. Furthermore, the scalability of the transfection technology combined with the HEK-293 platform has been extensively demonstrated at >100 L scale for several biologics, including recombinant viruses.Thus, this innovative approach is better suited to rationally engineer and mass produce influenza CVV within significantly shorter timelines to enable an effective global response in pandemic situations. 相似文献
10.